Related Experiment Video
Updated: May 17, 2025

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
Published on: November 8, 2017
Structural changes in cerebral microvasculature induced by ferroptosis contribute to blood-brain barrier disruption
Yuan Cao1, Mei-Ying Huang1, Chen-Hui Mao1
1Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Introduction:
Cerebrovascular lesions are associated with cognitive impairment. However, the impact of AD neuropathological changes (ADNC) on cerebral microvasculature is not completely understood.
Methods:
Twelve decedents with ADNC and 15 matched controls were selected from the Brain Bank. The changes in the median tunica and basement membrane-related extracellular matrix (ECM) contents of the microvasculature were quantified and compared. Additionally, we explored the related mechanisms of agrin in pericytes.
Results:
Venular collagenosis was significantly more severe in AD patients (p < 0.001), and ECM remolding was significantly correlated with ADNC. In the AD group, blood-brain barrier (BBB) disruption and decreased pericytes were observed. Finally, we confirmed that agrin induced ferroptosis in pericytes and BBB disruption in vitro.
Discussion:
Our data indicate that venular collagenosis and significant ECM remolding are important contributors to ADNC. The mechanism by which agrin's role in disrupting the BBB by inducing ferroptosis presents a potential new target.
Highlights:
Changes in the median tunica and basement membrane-related ECM contents of the microvasculature were quantified in human brains. Venular collagenosis was significantly more severe in AD patients. In the AD group, BBB disruption and ECM remodeling were important contributors to AD neuropathological changes. Agrin disrupted the BBB by inducing ferroptosis in pericytes, which presents a potential new target.
Related Concept Videos
The Blood-brain Barrier
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

